Log In
Print
BCIQ
Print
Print this Print this
 

Suprep (Eziclen/Izinova) (BLI-800)

  Manage Alerts
Collapse Summary General Information
Company Braintree Laboratories Inc.
DescriptionMixture of sodium, magnesium and potassium sulfates
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard Indication Gastrointestinal (unspecified)
Indication DetailsCleanse bowel prior to colonoscopy
Regulatory Designation

Partner

Ipsen Group


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today